Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Morphic Holding stock

Learn how to easily invest in Morphic Holding stock.

Morphic Holding Inc is a biotechnology business based in the US. Morphic Holding shares (MORF) are listed on the NASDAQ and all prices are listed in US Dollars. Morphic Holding employs 101 staff and has a trailing 12-month revenue of around $75.3 million.

How to buy shares in Morphic Holding

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – MORF – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Morphic Holding stock price (NASDAQ: MORF)

Use our graph to track the performance of MORF stocks over time.

Morphic Holding shares at a glance

Information last updated 2022-09-27.
Latest market close$28.30
52-week range$19.23 - $68.75
50-day moving average $28.64
200-day moving average $33.77
Wall St. target price$62.63
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-2.88

Buy Morphic Holding shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$0
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Public
Stocks, ETFs, Cryptocurrency
$0
$0
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Tradier
Stocks, Options, ETFs
$0
$0
N/A
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Morphic Holding stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Morphic Holding price performance over time

Historical closes compared with the close of $28.3 from 2022-09-30

1 week (2022-09-23) 8.93%
1 month (2022-09-02) -0.11%
3 months (2022-07-01) 27.31%
6 months (2022-04-01) -32.13%
1 year (2021-10-01) -47.55%
2 years (2020-10-02) 9.78%
3 years (2019-10-02) 62.08%
5 years (2017-09-28) N/A

Morphic Holding financials

Revenue TTM $75.3 million
Gross profit TTM $-67,995,000
Return on assets TTM -7.62%
Return on equity TTM -13.88%
Profit margin -67.85%
Book value $10.09
Market capitalisation $971.2 million

TTM: trailing 12 months

Morphic Holding share dividends

We're not expecting Morphic Holding to pay a dividend over the next 12 months.

Morphic Holding share price volatility

Over the last 12 months, Morphic Holding's shares have ranged in value from as little as $19.23 up to $68.75. A popular way to gauge a stock's volatility is its "beta".

MORF.US volatility(beta: 1.46)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Morphic Holding's is 1.4592. This would suggest that Morphic Holding's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Morphic Holding overview

Morphic Holding, Inc. , a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; and preclinical trial to treat idiopathic pulmonary fibrosis and fibrosis diseases. The company is also developing avß6 for the treatment of fibrotic diseases, and avß8 to treat solid tumors, as well as various other products. Morphic Holding, Inc. has a research collaboration with Engitix Ltd for the identification of Morphic integrin technology amenable targets in fibrostenotic IBD; a collaboration agreement with Schrödinger, LLC for integrin targets; and a license agreement with Children's Medical Center Corporation to develop and commercialize products worldwide for any therapeutic or diagnostic use in humans and veterinary applications. It also has collaboration agreements with AbbVie Biotechnology Ltd and Janssen Pharmaceuticals, Inc.

Frequently asked questions

What percentage of Morphic Holding is owned by insiders or institutions?
Currently 20.496% of Morphic Holding shares are held by insiders and 89.17% by institutions.
How many people work for Morphic Holding?
Latest data suggests 101 work at Morphic Holding.
When does the fiscal year end for Morphic Holding?
Morphic Holding's fiscal year ends in December.
Where is Morphic Holding based?
Morphic Holding's address is: 35 Gatehouse Drive, A2, Waltham, MA, United States, 02451
What is Morphic Holding's ISIN number?
Morphic Holding's international securities identification number is: US61775R1059
What is Morphic Holding's CUSIP number?
Morphic Holding's Committee on Uniform Securities Identification Procedures number is: 61775R105

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site